Medical News Today: Rybelsus and Reddit: Weight loss, heartburn, and other questions answered Insider on MSN: A new weight-loss pill is here. Here's how Foundayo compares to Wegovy, Zepbound, and other GLP-1 rivals. The FDA has approved Foundayo, a new weight-loss pill that could give Eli Lilly an edge over other drugmakers.

Understanding the Context

Here's how it compares to other GLP-1s. A new weight-loss pill is here. Here's how Foundayo compares to Wegovy, Zepbound, and other GLP-1 rivals. Semaglutide is helping patients achieve weight loss previously achievable only with bariatric surgery.

Key Insights

But at what cost? Reuters: Eli Lilly's weight-loss pill shows higher side effects than Novo rival in diabetes trial Feb 26 (Reuters) - Eli Lilly's (LLY.N), opens new tab experimental weight-loss pill, orforglipron, caused more side effects and treatment discontinuations than Novo Nordisk's (NOVOb.CO), opens new tab ... Eli Lilly's weight-loss pill shows higher side effects than Novo rival in diabetes trial